received a not approvable letter from the Food and Drug Administration for a new injection form of the schizophrenia treatment Zyprexa. Shares of Lilly were down 1.9% at $50.85 Thursday. Zyprexa, ...
Federal regulators are investigating the deaths of two patients who received injections of a longer-lasting version of Eli Lilly’s antipsychotic Zyprexa. The Food and Drug Administration said Tuesday ...
June 18 (Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results